Gene: ATG16L1
Official Full Name: autophagy related 16 like 1provided by HGNC
Gene Summary: The protein encoded by this gene is part of a large protein complex that is necessary for autophagy, the major process by which intracellular components are targeted to lysosomes for degradation. Defects in this gene are a cause of susceptibility to inflammatory bowel disease type 10 (IBD10). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jun 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01316 | ATG16L1 Knockout cell line (Vero) | Green monkey | ATG16L1 | 1:2~1:4 | Negative | Online Inquiry |
KO09465 | ATG16L1 Knockout cell line (HeLa) | Human | ATG16L1 | 1:3~1:6 | Negative | Online Inquiry |
KO09466 | ATG16L1 Knockout cell line (HCT 116) | Human | ATG16L1 | 1:2~1:4 | Negative | Online Inquiry |
KO09467 | ATG16L1 Knockout cell line (HEK293) | Human | ATG16L1 | 1:3~1:6 | Negative | Online Inquiry |
KO09468 | ATG16L1 Knockout cell line (A549) | Human | ATG16L1 | 1:3~1:4 | Negative | Online Inquiry |
ATG16L1 Gene Knockout Cell Lines are cutting-edge cellular models designed to study the biological implications of the ATG16L1 gene, which plays a crucial role in autophagy—a cellular degradation process essential for maintaining cellular homeostasis and responding to cellular stressors. The knockout of ATG16L1 leads to the disruption of autophagosome formation and has been implicated in several pathological conditions, including inflammatory bowel disease and various neurodegenerative disorders.
These cell lines are engineered using CRISPR-Cas9 techniques to ensure precise and efficient deletion of the ATG16L1 gene, thereby enabling researchers to explore the downstream effects of autophagy impairment. Their functionality is founded on the understanding that autophagy is a highly regulated process; manipulating this pathway can significantly affect cellular function and influence disease progression. By utilizing these knockout models, scientists can dissect the role of autophagy-related signaling pathways in health and disease, providing insights that can lead to novel therapeutic strategies.
The scientific importance of ATG16L1 Gene Knockout Cell Lines cannot be overstated. They are invaluable tools in research settings focusing on autophagy, inflammation, and cell survival, offering a unique perspective on how genetic variations can lead to changes in cellular behavior. Compared to traditional cell lines, ATG16L1 knockout models specifically allow for the study of autophagic dysfunction with greater accuracy and relevance, setting them apart from generic models.
For researchers and clinicians, the advantages of these cell lines include their ability to facilitate high-throughput screening and provide reproducible results, thereby expediting research timelines. Additionally, users benefit from the specificity of the models, which can yield clear, interpretable data for downstream applications, such as drug screening and biomarker discovery.
Our company, with expertise in genomic engineering and cell line development, is dedicated to providing high-quality biological products that empower researchers in the quest to unravel the complexities of human diseases. The ATG16L1 Gene Knockout Cell Lines embody our commitment to advancing scientific understanding and fostering innovation in the biomedical field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.